These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10091686)

  • 1. Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).
    Varie DL; Shih C; Hay DA; Andis SL; Corbett TH; Gossett LS; Janisse SK; Martinelli MJ; Moher ED; Schultz RM; Toth JE
    Bioorg Med Chem Lett; 1999 Feb; 9(3):369-74. PubMed ID: 10091686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel cryptophycin analogs with modification in the beta-alanine region.
    Shih C; Gossett LS; Gruber JM; Grossman CS; Andis SL; Schultz RM; Worzalla JF; Corbett TH; Metz JT
    Bioorg Med Chem Lett; 1999 Jan; 9(1):69-74. PubMed ID: 9990459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First generation design, synthesis, and evaluation of azepine-based cryptophycin analogues.
    Smith AB; Cho YS; Zawacki LE; Hirschmann R; Pettit GR
    Org Lett; 2001 Dec; 3(25):4063-6. PubMed ID: 11735585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
    Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
    Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
    Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
    J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total syntheses and biological investigations of tamandarins A and B and tamandarin A analogs.
    Liang B; Richard DJ; Portonovo PS; Joullié MM
    J Am Chem Soc; 2001 May; 123(19):4469-74. PubMed ID: 11457232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
    Georg GI; Ali SM; Stella VJ; Waugh WN; Himes RH
    Bioorg Med Chem Lett; 1998 Aug; 8(15):1959-62. PubMed ID: 9873466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
    Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
    J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cryptophycins: their synthesis and anticancer activity.
    Eggen M; Georg GI
    Med Res Rev; 2002 Mar; 22(2):85-101. PubMed ID: 11857635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
    Shih C; Teicher BA
    Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure--activity relationships of side-chain modified didemnins.
    Ding X; Vera MD; Liang B; Zhao Y; Leonard MS; Joullié MM
    Bioorg Med Chem Lett; 2001 Jan; 11(2):231-4. PubMed ID: 11206466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptophycin affinity labels: synthesis and biological activity of a benzophenone analogue of cryptophycin-24.
    Vidya R; Eggen M; Georg GI; Himes RH
    Bioorg Med Chem Lett; 2003 Feb; 13(4):757-60. PubMed ID: 12639575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological property of carba and 20-deoxo analogues of arenastatin A.
    Murakami N; Wang W; Tamura S; Kobayashi M
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1823-6. PubMed ID: 10969977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis and Biological Evaluation of a Structurally Simplified Syringolin A Analogues.
    Chiba T; Kitahata S; Matsuda A; Ichikawa S
    Chem Pharm Bull (Tokyo); 2016; 64(7):811-6. PubMed ID: 27373636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A convergent synthesis of (+)-cryptophycin B, a potent antitumor macrolide from Nostoc sp. cyanobacteria.
    Ghosh AK; Bischoff A
    Org Lett; 2000 Jun; 2(11):1573-5. PubMed ID: 10841482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cytostatic activities of didemnin derivatives.
    Schmidt U; Griesser H; Haas G; Kroner M; Riedl B; Schumacher A; Sutoris F; Haupt A; Emling F
    J Pept Res; 1999 Aug; 54(2):146-61. PubMed ID: 10461749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
    Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
    Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship study of syringolin A as a potential anticancer agent.
    Chiba T; Matsuda A; Ichikawa S
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4872-4877. PubMed ID: 26231162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.